Cogstate Limited (ASX:CGS)

Market Cap	469.77M
Revenue (ttm)	80.98M
Net Income (ttm)	15.47M
Shares Out	170.83M
EPS (ttm)	0.09
PE Ratio	30.93
Forward PE	30.37
Dividend	0.02 (0.72%)
Ex-Dividend Date	Aug 27, 2025

Volume	146,906
Average Volume	321,650
Open	2.800
Previous Close	2.770
Day's Range	2.720 - 2.800
52-Week Range	0.950 - 2.870
Beta	0.02
RSI	68.53
Earnings Date	Nov 20, 2025

About Cogstate

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophre...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CGS

Financial Performance

In 2025, Cogstate's revenue was $53.09 million, an increase of 22.25% compared to the previous year's $43.43 million. Earnings were $10.14 million, an increase of 86.15%.

Financial numbers in USD